创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Advantages of Humanized Models of the Immune System

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-22 16:10
  • Views:

(Summary description)With the rapid development of the biomedical field, understanding the function of the immune system and disease mechanisms has become an important prerequisite for disease diagnosis and treatment. As an advanced biomedical research tool, the humanized model of the immune system is helping us to gain a deeper understanding of the complexity and diversity of the human immune system, and advancing the progress of medical research.

InnoModels Biotechnology: Advantages of Humanized Models of the Immune System

(Summary description)With the rapid development of the biomedical field, understanding the function of the immune system and disease mechanisms has become an important prerequisite for disease diagnosis and treatment. As an advanced biomedical research tool, the humanized model of the immune system is helping us to gain a deeper understanding of the complexity and diversity of the human immune system, and advancing the progress of medical research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-22 16:10
  • Views:
Information

With the rapid development of the biomedical field, understanding the function of the immune system and disease mechanisms has become an important prerequisite for disease diagnosis and treatment. As an advanced biomedical research tool, the humanized model of the immune system is helping us to gain a deeper understanding of the complexity and diversity of the human immune system, and advancing the progress of medical research.
What is the Genomics Humanized Model of the Immune System?
The Humanized Immunity System Model, or HIS model for short, is an experimental model based on gene editing and cell engineering technologies. The model introduces key components of the human immune system (e.g., immune cells, immune-related genes, etc.) into experimental animals so that they have functions and responses similar to those of the human immune system. This model is able to simulate the response of the human immune system under various physiological and pathological conditions, providing a powerful tool for the study of immune-related diseases.
Advantages of InnoModels' humanized model of the immune system
1. Highly humanized: the humanized model of the biomimetic immune system is highly similar to the human immune system in terms of immune cell types, immune-related gene expression and regulation, and therefore can more accurately reflect the biological characteristics of the human immune system.
2. High controllability: Through gene editing technology, researchers can precisely manipulate the immune cells in the model, such as regulating gene expression and altering cell function. This controllability enables researchers to gain a deeper understanding of the functional mechanisms of the immune system and the disease process.
3. Wide scope of application: The InnoMod Bioimmune System Humanized Model can be applied to the study of a variety of immune-related diseases, such as autoimmune diseases, infectious diseases, tumors and so on. In addition, the model can also be used for drug screening and immunotherapy strategy development.

 


Prospects for the application of the InnoModels Bioimmune System Humanized Model
The humanized model of biomimetic immune system has a broad application prospect in the field of biomedical research. With the continuous development and improvement of the technology, the model will play an important role in the following aspects:
1. Disease mechanism research: By simulating the function and response of the human immune system, the humanized model of the biomimetic immune system can help to reveal the pathogenesis of immune-related diseases and provide new ideas and methods for disease diagnosis and treatment.
2. Drug discovery and development: The humanized model of the modeling bioimmune system can be used as an important tool for drug screening and evaluation, helping researchers to identify potential drug candidates and assess their effects and safety in vivo.
3. Research and development of immunotherapeutic strategies: The model can be used to study the effectiveness and safety of immunotherapeutic strategies, such as immune cell therapy and immunomodulatory drugs. By optimizing immunotherapy strategies, it is expected to improve the treatment effect of the disease and the quality of life of patients.
Summary and Prospect
As a revolutionary tool in the field of biomedical research, the InnoModels Bioimmune System Humanized Model provides us with powerful support for a deeper understanding of the complexity and diversity of the human immune system. With the continuous development and improvement of the technology, the model will play an increasingly important role in the study of disease mechanisms, drug discovery and development of immunotherapy strategies. In the future, we have reason to believe that the humanized model of the immune system will become an important force in medical research and therapeutic technology innovation.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司